BENZOIMIDAZOL-2-YL PYRIMIDINES AND PYRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR

Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis. L'invention concerne des benzoimidazol-2-yl pyrimi...

Full description

Saved in:
Bibliographic Details
Main Authors EDWARDS, JAMES, P, VENABLE, JENNIFER, D, KINDRACHUK, DAVID, E
Format Patent
LanguageEnglish
French
Published 18.10.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Benzoimidazol-2-yl pyrimidines and pyrazines, pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, including allergy, asthma, autoimmune diseases, and pruritis. L'invention concerne des benzoimidazol-2-yl pyrimidines et des pyrazines, des compositions pharmaceutiques et des méthodes de traitement d'états pathologiques, de troubles et de conditions médiés par l'activité du récepteur de H4, y compris les allergies, l'asthme, les maladies auto-immunes et les prurits.
Bibliography:Application Number: WO2007US08216